Nitric oxide (NO) has been known to play various functional and pathological roles as an intracellular or intercellular messenger in the heart. In this study, we investigated whether NO produced during ischemia was involved in the coordination of ATP supply and demand, and also in protection from cell death using cultured cardiac myocytes. Unexpectedly, the survival rate of myocytes for 3 h simulated ischemia (SI) was increased as compared with that for 2 h SI at 24 h after reperfusion. The cellular ATP level at 3 h after the start of SI was increased compared with that at 2 h, and was almost the same as that before the start of SI. The cellular ATP level at 3 h SI was significantly reduced by either the inhibition of nitric oxide synthase (NOS) or scavenging of NO. Either the inhibition of NOS or the scavenging of NO during SI for 3 h also resulted in a significant decrease in the survival rate of myocytes.
Introduction
Normal myocardium generates more than 90% of its ATP by oxidative metabolism and less than 10% by anaerobic glycolysis [1] . During severe cardiac ischemia, the heart is deprived of oxygen and energy substrates such as glucose and fatty acids. Metabolic arrest achieved by means of a reversed or negative Pasteur effect (reduced or unchanging glycolytic flux) is an important cardioprotective response to ischemic stress [2] . This means that cardiac myocytes must drastically reduce ATP demand or utilization to meet the needs for survival, and thus balance reduced ATP supply with reduced demand during severe ischemia. In fact, severe hypoxic stress reduces the demand for ATP by decreasing a variety of ATP-consuming cell functions including the activities of muscle contraction [3] , protein synthesis, and RNA synthesis [4, 5] which are the major ATP-consuming process in cardiac myocytes.
Nitric oxide (NO) is a ubiquitous signaling molecule produced from L-arginine by nitric oxide synthase (NOS), and is known to play a variety of functional and/or pathophysiological roles in living tissues or cells [6, 7] . The activity of NOS in the heart is stimulated by ischemia, and the activated NOS produces NO after the onset of ischemia [8] . Therefore, NO presumably contribute to ischemia-induced dysfunction of the heart such as increased vulnerability to ventricular tachyarrhythmias [9] , and cardiac cell death [10, 11] .
In fact, treatment of adult ventricular myocytes with an NO donor resulted in a marked increase in p53 expression, and induced apoptosis [12] .
However, we have recently found that NO produced during ischemia is crucial to the development of preconditioning-induced ischemic tolerance of neurons in culture [13] .
It has also been suggested that production of NO represents one paracrine/autocrine mechanism coordinating energy supply and demand in tissues [14] . Thus, the pathological as well as functional roles of NO produced during ischemia in cardiac functions are not clear.
Here we provide experimental evidence that the enhanced production of NO was critically involved in balancing ATP supply and demand during ischemia, and also in protecting cells from ischemia/reperfusion-induced injury.
Methods

Culture of cardiac myocytes
The animal experiments conformed to the "Principles of laboratory animal care" (NIH publication No. 85-23, revised 1996), as well as the "guide for the care and use of laboratory animals", Hokkaido University School of Medicine (Hokkaido, Japan).
The method of culturing cardiac myocytes was described elsewhere in detail [15] . In short, cardiac myocytes were prepared from 1-to -3 day old neonatal Wistar rat ventricles removed after decapitation. The ventricles were rinsed in a 25 mM HEPES buffered minimum salt solution (MSS) to remove contaminating blood cell components and then minced with scissors into fragments to be digested with 0.1% collagenase (Wako Chemical, Tokyo, Japan) in MSS at 37 ˚C for 10 min. The cell components were suspended in MCDB 107 (Research Institute for Functional Peptides, Yamagata, Japan) containing 5% FCS (MBL, Nagoya, Japan), and then passed through a wire mesh screen (90 µm porosity) to remove large aggregates of cells; the filtered suspension contains cardiac myocytes and fibroblasts. To separate cardiac myocytes 6 from fibroblasts based on the selective adhesion technique [16] , the cell suspension was poured in petri dishes (60×15 mm, Falcon), and incubated for 60 min at 37 ˚C, in 5% CO 2 and 95% air. By virtue of the procedure, most of the fibroblasts adhere to the dish.
After the incubation, the suspension, in which most cell components were cardiac myocytes, was collected. The cells were resuspended in MCDB 107 containing 5% FCS, transferrin (10 µg/ml, Sigma, St. Louis, MO), and insulin (10 µg/ml, Yamanouchi, Tokyo, Japan). The cell suspension was passed through a fine wire mesh screen (26 µm porosity) to remove remaining small aggregates of myocytes, and finally the isolated myocytes remaining were cultured at a density of about 3.0 × 10 5 cells/ml in a petri dish coated beforehand with fibronectin (10 µg/ml, Sigma). Cardiac myocytes cultured for 5 days were used in this study.
Simulated ischemia/reperfusion
The experimental protocol used to simulate ischemia/reperfusion was a modified version of the method proposed by Rakhit and his colleagues [17] . This procedure is described elsewhere in detail [18] . In short, serum-containing incubation medium was exchanged with serum-free DMEM (Gibco BRL, Invitrogen Corp., Carlsbad, CA) 2 h before the start of experiments. After pre-gassing with 95% N 2 -5% CO 2 for at least 5 min, ischemia buffer was added to the cells, which were then placed in a sealed chamber containing the deoxygenation reagent (Kenki for Cells, Mitsubishi Gas Chemical). The catalytic reaction of the reagent resulted in the consumption of O 2 and in the production of CO 2 . This Anaero-Pack System provided near anaerobic conditions with an O 2 concentration of < 1% and a CO 2 concentration of about 5% within 1 h of incubation at 37 °C. This hypoxia/anoxia stress to cardiac myocytes is defined as "simulated ischemia". Cells were exposed to these conditions for 2 h or 3 h, and then incubated again in glucose-containing DMEM at 37 °C in 95% air-5% CO 2 (reperfusion).
ATP and lactate measurement
ATP was quantified in cardiac myocyte cultures 2 h and 3 h after the start of SI using a commercially available luciferin-luciferase assay kit (Total ATP Rapid Biocontamination Detection Kit, Promega, WI, USA) [19] . The cells were placed in 400 μl of Tris-HCl buffer, and lysis reagent was added 20 min later. The lysate was mixed with a micropipette, and transferred to a microcentrifuge tube. The diluted lysate (100 μl) was added to a polystyrene tube containing 300 μl of Swab buffer, and then rL/L reagent was added. The tube was placed in a Luminometer (TD-2020, TURNER DESIGN). To confirm whether the quantification of cellular ATP by this method was valid, cellular respiration was inhibited by treatment of cultures with carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP, 1 μM), an uncoupler of mitochondrial respiration, for 10 min.
The L-lactic acid concentrations in the culture medium were quantified using a commercially available assay kit (F-kit L-Lactate, JK International, Tokyo, Japan) 2 h and 3 h after the start of SI [20] .
Immunohistochemical analyses using anti-NOS antibodies
The nitric oxide synthases (NOS) in cultured cells were detected by 
Evaluation of cell viability
Cell viability was analyzed following visualization of the nuclear morphology with the fluorescent DNA-binding dyes, Hoechst 33342 (bisbenzimide) and propidium iodide (PI). Cells were incubated with these dyes for 15 min at 37 °C. Individual nuclei were visualized using fluorescent microscopy (Olympus, IX70) and analyzed; PI was used to identify nonviable cells. An average of 450-500 cardiac myocytes from random fields were analyzed in each experiment. The survival rate of myocytes (percentage of viable myocytes) was determined by placing images of nuclear staining on phase-contrast images, and calculated as (viable myocytes/total myocytes before the onset of SI) × 100, since some myocytes came off from the dishes at the time of inspection. Six independent experiments (n=6 different cultures) were performed and analyzed.
Monitoring of cytosolic nitric oxide production
Changes in the cytosolic NO concentration were monitored using a fluorescent NO probe, DAF-FM [21] . Cells were loaded with NO indicator by incubation with 10 μM 
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Because DAF-FM is not a quantitative probe like DAF-2 [21] , no attempt was made to calibrate DAF-FM fluorescence.
Experimental protocol
In all experiments, cell viability was analyzed 24 h after the start of reperfusion, since delayed death (apoptosis) of cardiac myocytes could be observed long after the ischemic insult in some cases [22, 23] .
To investigate whether the NOS-derived NO is involved in the preservation of 
Statistics
Data are represented as the mean±S.D. Inter-group comparisons were performed using the one-way analysis of variance (ANOVA) followed by a paired t-Test.
Differences with a value of P<0.05 were considered significant.
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Results
Ischemia/reperfusion-induced death of cardiac myocytes
We first investigated whether the exposure of cultured cardiac myocytes to simulated ischemia (SI) and 24 h reperfusion evoked cell death while changing the duration of SI to 1, 2, and 3 h ( Fig. 1) . Surprisingly, exposure to 2h SI resulted in the significant death of cardiac myocytes at 24 h after the start of reperfusion ( Fig. 1C & E) , but exposure to 3 h SI did not ( Fig. 1D & E) . The survival rate of cardiac myocytes when the cultures were exposed to 3 h SI was almost the same as that of controls without SI or with 1h SI. This means that as the duration of the ischemia increased, the survival rate of cardiac myocytes rose. This unexpected result raises the question as to what mechanisms are responsible for the ischemia/reperfusion-induced death of cardiac myocytes. We therefore investigated the metabolic status of cardiac myocytes during SI.
Nitric oxide involved in the coordination of ATP supply and demand
Exposure of cardiac myocytes to SI stress tended to decrease the cellular ATP level at 2 h after the onset of SI ( Fig. 2A & B) . Interestingly, cellular ATP level at 3 h SI was increased compared with that at 2 h SI, and was almost the same concentration as that of the control before the onset of SI, suggesting that cellular ATP was strictly regulated for the close matching of supply and demand at this time. SI increased lactate output at both 2 and 3 h after the onset of SI, but there was not significant difference between the outputs at 2 and 3 h SI ( Fig. 2C & D) .
A previous study has suggested that production of NO represents one paracrine/autocrine mechanism coordinating energy supply and demand in tissues [14] .
Thus, we investigated whether the NO produced during SI changed the metabolic status of cardiac myocytes. Treatment of the cultures with either L-NMMA (1 mM) or carboxy-PTIO (100 μM) during SI did not change the cellular ATP level at 2 h SI.
However, at 3 h SI, treatment with either L-NMMA or carboxy-PTIO resulted in a significant decrease in the cellular ATP level ( Fig. 2A & B) . SI increased lactate output, but treatment of the cultures with either L-NMMA or carboxy-PTIO did not change the lactate level significantly (Fig. 2C & D) . Thus, an NO-dependent change in the cellular ATP level was observed only at 3 h after the onset of SI. 18 We then confirmed that the decrease in cellular ATP on treatment of the cultures with either L-NMMA or carboxy-PTIO observed at 3 h SI was not caused by a decrease in the number of cardiac myocytes; that is, cell death. At 3 h after the onset of SI, a significant loss of cardiac myocytes was not observed ( Fig. 2E) , indicating that the decrease in cellular ATP on treatment of the cultures with either L-NMMA or carboxy-PTIO observed at 3 h SI was not due to myocyte death. This result also suggested that reperfusion after SI was necessary for the significant induction of cell death among myocytes, and cardiac myocytes probably adapted to this ischemic environment and survived to at least at 3 h SI.
We then confirmed that NO is responsible for the coordination of ATP supply and demand at 3 h after the start of SI (Fig. 3A) . Treatment of cultures with L-NMMA (1 mM) significantly decreased the cellular ATP level at 3 h SI. Co-treatment with L-NMMA (1 mM) and SNAP (10 μM) significantly antagonized the L-NMMA-induced decrease in cellular ATP, but co-treatment with decomposed SNAP did not.
Nitric oxide and ischemia/reperfusion-induced cell death
We next investigated whether the NO produced during ischemia was protective of cardiac myocytes when the cultures were exposed to 3 h SI and 24 h reperfusion ( Fig.   3B -E). The inhibition of the nitric oxide synthase (NOS) activity with L-NMMA (1 mM) during SI resulted in a significant decrease in the survival rate of myocytes at 24 h after the start of reperfusion. The decrease in the rate of survival caused by treatment with L-NMMA during SI was significantly antagonized by co-treatment with SNAP (10 μM), an NO donor, but not with decomposed SNAP (10 μM). These results suggested that NO produced during SI protected myocytes from ischemia/reperfusion-induced death.
Cellular ATP at 3 h SI was maintained at almost the same concentration as that of the control before the onset of SI, and NO produced during SI was critically involved in this preservation of cellular ATP. An NO-dependent change in the cellular ATP level was unexpectedly observed at 3 h after the onset of SI, suggesting that the production of NO was enhanced at this time. Thus, we then investigated whether the expression of NOS isoforms (nNOS, iNOS, and eNOS) changed at 3 h after the onset of SI by conducting immunocytochemical and Western blot analyses (Fig. 4) . The expression 20 of nNOS was most evident in cardiac myocytes, but no significant change was observed in the expression of any of the isoforms at 2 h SI or at 3 h SI ( Fig. 4A-C) .
Increased production of nitric oxide during ischemia
Therefore, we next investigated whether NO production really increased during the present protocol of simulated ischemia (SI), especially at 3 h SI. To do this, the fluorescent NO probe DAF-FM DA was used to estimate the changes in the cytosolic NO concentration of cultured cardiac myocytes (Fig. 5 ). DAF-FM fluorescence in myocytes gradually increased with time after the onset of SI, especially at 3 h SI ( Fig.   5A & C). The fluorescent intensity at 3 h SI was significantly higher than that at 2 h SI (Fig. 5D ). The increase in intracellular DAF-FM fluorescence was significantly suppressed by treating the cultures with 100 μM vinyl-L-NIO (L-VNIO), a potent specific inhibitor of nNOS [24] (Fig. 5B-D) . DAF-FM fluorescence was also significantly suppressed by treatment with 1 mM L-NMMA, a non-specific inhibitor of NOS (data not shown). These results suggested that SI resulted in an increase in the production of NO, probably via the activation of nNOS, in cultured cardiac myocytes, especially at 3 h SI. The relatively rapid time course of the increase in the DAF fluorescent intensity reflecting increased NO production during SI suggested that NO was produced by constitutive NOS (cNOS), not by iNOS [17] .
Involvement of nNOS-derived nitric oxide
We finally investigated whether the nNOS-derived NO produced during SI was involved in the preservation of cellular ATP at 3 h SI as well as in the protection of cardiac myocytes from reperfusion-induced cell death (Fig. 6 ). Treatment of cultures with 100 μM L-VNIO resulted in a significant decrease in cellular ATP. Co-treatment with SNAP (10 μM) significantly antagonized the L-VNIO-induced reduction in cellular ATP, but co-treatment with decomposed SNAP (10 μM) did not (Fig. 6A ).
Treatment of cultures with L-VNIO also resulted in a significant decrease in the survival rate of cardiac myocytes at 24 h after reperfusion ( Fig. 6B-E) . Co-treatment with SNAP (10 μM) significantly antagonized the L-VNIO-induced reduction in the rate of survival of myocytes, but co-treatment with decomposed SNAP did not. These results suggested that enhanced production of nNOS-derived NO was involved in the preservation of cellular ATP during SI, and the protection of cardiac myocytes from ischemia/reperfusion-induced death.
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Discussion
The present study revealed that the increase in the production of NO during simulated ischemia (SI) was critically involved in balancing ATP supply and demand during ischemia, and in protecting cells from ischemia/reperfusion-induced injury.
Reperfusion, not simulated ischemia, induces death of cardiac myocytes
No significant death of cardiac myocytes was observed for 3 h SI as compared with control cultures without ischemic stress even when cultures were treated with either L-NMMA or carboxy-PTIO ( Fig. 2 ), suggesting that almost all the myocytes survived during a prolonged ischemia of at least 3 h and reperfusion is necessary for the induction of myocyte death. This finding is in agreement with the report that chick embryonic cardiomyocytes exposed to a prolonged SI for 4 h exhibited only a marginal increase in cell death [25] . These findings have raised the question as to what mechanisms were responsible for the increase in cell death when cultured myocytes were treated with L-NMMA or carboxy-PTIO during SI. Co-treatment with L-NMMA and SNAP during SI increased the survival rate of myocytes at reperfusion (Fig. 3E ), suggesting that NO produced during SI rescued myocytes from reperfusion-induced death.
Either the inhibition of NOS activity or the scavenging of NO during SI for 3h resulted in the significant decrease in cellular ATP (Fig. 2 ). This suggests that NO produced during ischemia was involved in the preservation of cellular ATP during ischemia. Tsukube et al. demonstrated in isolated rabbit hearts that the preservation of high-energy phosphates is essential for the reduction of reperfusion-induced Ca 2+ overload [26] . A deficiency of ATP at the onset of reperfusion may inhibit the activity of Na + /K + -ATPase (Na + -pump), and cause Na + to accumulate in cardiac myocytes during reperfusion [27] . A loss of Na + homeostasis during reperfusion results in the dysfunction of secondary ionic active transporters such as the Na + /H + or Na + /Ca 2+ exchanger. Reversed uptake of Ca 2+ via the Na + /Ca 2+ exchanger produces Ca 2+ overload in myocardium upon reperfusion [28, 29] . Ca 2+ overload and a resultant fall in mitochondrial membrane potential (ΔΨ m ) may induce mitochondrial permeability transition, which is an initiating step for apoptosis and necrosis [30] .
NO is involved in the coordination of ATP supply and demand during ischemia
The cellular ATP concentration was almost the same at 3 h SI as before the onset of SI, although it decreased at 2 h SI ( Fig. 2A & B) . In addition, cellular ATP at 3 h SI was significantly decreased by treatment with either L-NMMA or carboxy-PTIO during SI, but not at 2 h SI ( Fig. 2A & B) . Cellular ATP at 3 h SI was also decreased by treatment with vinyl-L-NLO, a potent specific inhibitor of nNOS [24] (Fig. 6 ). The decrease in cellular ATP at 3 h SI caused by either L-NMMA or vinyl-L-NIO was significantly antagonized by co-treatment with an NO donor SNAP, but not with decomposed SNAP (Fig. 3 & Fig. 6 ). These results suggested that NO produced during SI by NOS, especially by nNOS, was crucially involved in the coordination of ATP supply and demand during SI. It has been generally considered that the maintenance of the energy balance and of stable steady-state ATP concentrations in hypoxia-tolerant cells is a sign of an effective defense against anoxia or ischemia [31, 32] . Thus, the cultured cardiac myocytes from neonatal rats used in this study seem to be "hypoxia tolerant", not "hypoxia sensitive" cells, since one of the features of "hypoxia sensitive" cells is that ATP synthesis cannot meet energy requirements [2] .
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Cellular ATP at 3 h SI tended to increase as compared with that at 2 h SI, but lactate output remained about the same between 2 h and 3 h SI (Fig. 2) . In addition, lactate output during SI was not significantly changed by treatment with either L-NMMA or carboxy-PTIO. These results suggested that anaerobic glycolysis was not enhanced markedly at 3 h SI as compared with 2 h SI, and was probably independent of the NO produced during SI. Therefore, the NO produced during SI may suppress ATP utilization in order to match the decreased ATP supply due to ischemic stress to cardiac myocytes.
The question then arises as to what mechanisms are responsible for the NO-induced suppression of ATP utilization of cardiac myocytes during ischemia.
Exact mechanisms are currently unknown, but one possibility is that NO produced during SI may contribute to a down-regulation of proton leak in the mitochondria.
Mitochondrial membrane potential cannot be abolished completely during anoxia since it is crucially needed to import proteins that ensure mitochondrial maintenance [33] .
During normoxia, the futile cycle of mitochondrial proton pumping and proton leak across the inner mitochondrial membrane is estimated to make up about 20% of the standard metabolic rate of mammals [34] . During anoxia or ischemia, the inverse operation of F1,F0-ATPase attempts to maintain the mitochondrial membrane potential by using ATP to translocate protons back into the intermembrane space. This means that mitochondrial F1,F0-ATPase is a ATP consumer, not a ATP producer, in the absence of oxygen [35] . Since rat cardiac myocytes contain small amounts of higher affinity F1-ATPase inhibitory subunit (IF1) [36] , there is a possibility that the most effective strategy of cardiac myocytes reducing ATP utilization during ischemia is a down-regulation of proton leak in the mitochondria. Further studies will be needed to clarify this. 
Figure Legends
